237
Views
37
CrossRef citations to date
0
Altmetric
Original Research

Studies of synthetic chalcone derivatives as potential inhibitors of secretory phospholipase A2, cyclooxygenases, lipoxygenase and pro-inflammatory cytokines

, , &
Pages 1405-1418 | Published online: 16 Sep 2014

References

  • Yang H Gu J Lin X Profiling of Genetic Variations in Inflammation Pathway Genes in Relation to Bladder Cancer Predisposition Clin Cancer Res 2008 14 7 2236 2244 18381966
  • McInnes IB Schett G Cytokines in the pathogenesis of rheumatoid arthritis Nat Rev Immunol 2007 7 6 429 442 17525752
  • Esch T Stefano G Proinflammation: a common denominator or initiator of different pathophysiological disease processes Med Sci Monit 2002 8 5 HY1 HY9 12011758
  • Dinarello CA Inflammatory cytokines: interleukin-1 and tumor necrosis factor as effector molecules in autoimmune diseases Curr Opin Immunol 1991 3 6 941 948 1665333
  • Arend WP Dayer JM Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis Arthritis Rheum 1990 33 3 305 315 2180403
  • Dayer JM Demczuk S Cytokines and other mediators in rheumatoid arthritis Springer Semin Immunopathol 1984 7 4 387 413 6395411
  • Barnes PJ Chung KF Page CP Inflammatory mediators of asthma: an update Pharmacol Rev 1998 50 4 515 596 9860804
  • Loyau G Pujol JP The role of cytokines in the development of osteoarthritis Scand J Rheumatol Suppl 1990 81 8 12 2406894
  • Kirkham B Interleukin-1, immune activation pathways, and different mechanisms in osteoarthritis and rheumatoid arthritis Ann Rheum Dis 1991 50 6 395 400 2059083
  • Nickoloff BJ The immunologic and genetic basis of psoriasis Arch Dermatol 1999 135 9 1104 1110 10490116
  • Saklatvala J Davis W Guesdon F Interleukin 1 (IL1) and tumour necrosis factor (TNF) signal transduction Philos Trans R Soc Lond B Biol Sci 1996 351 1336 151 157 8650261
  • Sacca R Cuff CA Ruddle NH Mediators of inflammation Curr Opin Immunol 1997 9 6 851 857 9492989
  • Matsui T Kondo T Nishita Y Highly potent inhibitors of TNF-alpha production. Part I: discovery of new chemical leads and their structure-activity relationships Bioorg Med Chem 2002 10 12 3757 3786 12413832
  • Kim KJ Lee JS Kwak MK Anti-inflammatory action of mollugin and its synthetic derivatives in HT-29 human colonic epithelial cells is mediated through inhibition of NF-kappaB activation Eur J Pharmacol 2009 622 1–3 52 57 19765578
  • Esposito E Cuzzocrea S TNF-alpha as a therapeutic target in inflammatory diseases, ischemia-reperfusion injury and trauma Curr Med Chem 2009 16 24 3152 3167 19689289
  • Mendis E Kim MM Rajapakse N Kim SK Suppression of cytokine production in lipopolysaccharide-stimulated mouse macrophages by novel cationic glucosamine derivative involves down-regulation of NF-kappaB and MAPK expressions Bioorg Med Chem 2008 16 18 8390 8396 18786831
  • Aitdafoun M Mounier C Heymans F Binisti C Bon C Godfroid JJ 4-Alkoxybenzamidines as new potent phospholipase A2 inhibitors Biochem Pharmacol 1996 51 6 737 742 8602868
  • Kurumbail RG Stevens AM Gierse JK Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents Nature 1996 384 6610 644 648 8967954
  • Marnett LJ The COXIB experience: a look in the rearview mirror Annu Rev Pharmacol Toxicol 2009 49 265 290 18851701
  • Kitamura T Itoh M Noda T Matsuura M Wakabayashi K Combined effects of cyclooxygenase-1 and cyclooxygenase-2 selective inhibitors on intestinal tumorigenesis in adenomatous polyposis coli gene knockout mice Int J Cancer 2004 109 4 576 580 14991580
  • Sano H Noguchi T Miyajima A Hashimoto Y Miyachi H Anti-angiogenic activity of basic-type, selective cyclooxygenase (COX)-1 inhibitors Bioorg Med Chem Lett 2006 16 11 3068 3072 16513348
  • Chakraborti AK Garg SK Kumar R Motiwala HF Jadhavar PS Progress in COX-2 inhibitors: a journey so far Curr Med Chem 2010 17 15 1563 1593 20166930
  • Singh P Mittal A Current status of COX-2 inhibitors Mini Rev Med Chem 2008 8 1 73 90 18220987
  • Langford RM Mehta V Selective cyclooxygenase inhibition: its role in pain and anaesthesia Biomed Pharmacother 2006 60 7 323 328 16837162
  • Eberhart CE Coffey RJ Radhika A Giardiello FM Ferrenbach S DuBois RN Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas Gastroenterol 1994 107 4 1183 1188
  • Dannenberg AJ Lippman SM Mann JR Subbaramaiah K DuBois RN Cyclooxygenase-2 and epidermal growth factor receptor: pharmacologic targets for chemoprevention J Clin Oncol 2005 23 2 254 266 15637389
  • Bukhari SN Jasamai M Jantan I Synthesis and biological evaluation of chalcone derivatives (mini review) Mini Rev Med Chem 2012 12 13 1394 1403 22876958
  • Bukhari SN Jantan I Jasamai M Anti-inflammatory trends of 1,3-diphenyl-2-propen-1-one derivatives Mini Rev Med Chem 2013 13 1 87 94 22876943
  • Bandgar BP Gawande SS Bodade RG Totre JV Khobragade CN Synthesis and biological evaluation of simple methoxylated chalcones as anticancer, anti-inflammatory and antioxidant agents Bioorg Med Chem 2010 18 3 1364 1370 20064725
  • Gómez-Rivera A Aguilar-Mariscal H Romero-Ceronio N Roa-de la Fuente LF Lobato-García CE Synthesis and anti-inflammatory activity of three nitro chalcones Bioorg Med Chem Lett 2013 23 20 5519 5522 24012185
  • Kil JS Son Y Cheong YK Okanin, a chalcone found in the genus Bidens, and 3-penten-2-one inhibit inducible nitric oxide synthase expression via heme oxygenase-1 induction in RAW264.7 macrophages activated with lipopolysaccharide J Clin Biochem Nutr 2012 50 1 53 58 22247601
  • Ramesh B Sumana T Synthesis and Anti-Inflammatory Activity of Pyrazolines J Chem 2010 7 2 514 516
  • Bharate SB Mahajan TR Gole YR Synthesis and evaluation of pyrazolo[3,4-b]pyridines and its structural analogues as TNF-alpha and IL-6 inhibitors Bioorg Med Chem 2008 16 15 7167 7176 18625560
  • Lorenzo P Alvarez R Ortiz MA Alvarez S Piedrafita FJ de Lera AR Inhibition of IkappaB kinase-beta and anticancer activities of novel chalcone adamantyl arotinoids J Med Chem 2008 51 17 5431 5440 18702457
  • Rao YK Fang SH Tzeng YM Synthesis and biological evaluation of 3′,4′,5′-trimethoxychalcone analogues as inhibitors of nitric oxide production and tumor cell proliferation Bioorg Med Chem 2009 17 23 7909 7914 19875299
  • Srinivasan B Johnson TE Lad R Xing C Structure-activity relationship studies of chalcone leading to 3-hydroxy-4,3′,4′,5′-tetramethoxychalcone and its analogues as potent nuclear factor kappaB inhibitors and their anticancer activities J Med Chem 2009 52 22 7228 7235 19883086
  • Bukhari SN Tajuddin Y Benedict VJ Synthesis and Evaluation of Chalcone Derivatives as Inhibitors of Neutrophils’ Chemotaxis, Phagocytosis and Production of Reactive Oxygen Species Chem Biol Drug Des 2014 83 2 198 206 24433224
  • Bukhari SN Jantan I Wai LK Lajis NH Abbas F Jasamai M Synthesis and effects of pyrazolines and isoxazoles on the phagocytic chemotaxis and release of reactive oxygen species by zymosan stimulated human neutrophils Med Chem 2013 9 8 1091 1098 23092331
  • Ellman GL Courtney KD Andres VJr Featherstone RM A new and rapid colorimetric determination of acetylcholinesterase activity Biochem Pharmacol 1961 7 2 88 95 13726518
  • Blobaum AL Marnett LJ Structural and functional basis of cyclooxy-genase inhibition J Med Chem 2007 50 7 1425 1441 17341061
  • Cardozo T Totrov M Abagyan R Homology modeling by the ICM method Proteins 1995 23 3 403 414 8710833
  • Duggan KC Walters MJ Musee J Molecular basis for cyclooxy-genase inhibition by the non-steroidal anti-inflammatory drug naproxen J Bio Chem 2010 285 45 34950 34959 20810665
  • Saul FA Prijatelj-Žnidaršič P Vulliez-le Normand B Comparative structural studies of two natural isoforms of ammodytoxin, phospholipases A2 from Vipera ammodytes ammodytes which differ in neurotoxicity and anticoagulant activity J Struct Biol 2010 169 3 360 369 19857576
  • Strynadka NC Eisenstein M Katchalski-Katzir E Molecular docking programs successfully predict the binding of a beta-lactamase inhibitory protein to TEM-1 beta-lactamase Nat Struct Biol 1996 3 3 233 239 8605624
  • Kim HP Son KH Chang HW Kang SS Anti-inflammatory plant flavonoids and cellular action mechanisms J Pharmacol Sci 2004 96 3 229 245 15539763
  • Wang Y Xu W Shao H Xie Y Wang J Design and Synthesis of Novel Pyrazole-based Lp-PLA2 Inhibitors Chinese Journal of Chemistry 2011 29 10 2039 2048
  • Zhang Y Zhao C He W Discovery and evaluation of asymmetrical monocarbonyl analogs of curcumin as anti-inflammatory agents Drug Des Devel Ther 2014 8 373 382
  • Ahmad W Kumolosasi E Jantan I Bukhari SNA Jasamai M Effects of Novel Diarylpentanoid Analogues of Curcumin on Secretory Phospholipase A2, Cyclooxygenases, Lipo-oxygenase, and Microsomal Prostaglandin E Synthase-1 Chem Biol Drug Des 2014 83 6 670 681 24406103
  • Seibert K Zhang Y Leahy K Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain Proc Natl Acad Sci U S A 1994 91 25 12013 12017 7991575
  • Willingale HL Gardiner NJ McLymont N Giblett S Grubb BD Prostanoids synthesized by cyclo-oxygenase isoforms in rat spinal cord and their contribution to the development of neuronal hyperexcitability Br J Pharmacol 1997 122 8 1593 1604 9422803
  • Katsori AM Chatzopoulou M Dimas K Curcumin analogues as possible anti-proliferative and anti-inflammatory agents Eur J Med Chem 2011 46 7 2722 2735 21514701
  • Stoll LL Denning GM Weintraub NL Endotoxin, TLR4 signaling and vascular inflammation: potential therapeutic targets in cardiovascular disease Curr Pharm Des 2006 12 32 4229 4245 17100625